Differential expression of genes encoding membrane proteins between acute and continuous Chlamydia pneumoniae infections

被引:27
作者
Hogan, RJ
Mathews, SA
Kutlin, A
Hammerschlag, MR
Timms, P
机构
[1] Queensland Univ Technol, Sch Life Sci, Cooperat Res Ctr Diagnost, Ctr Mol Biotechnol, Brisbane, Qld 4000, Australia
[2] SUNY Downstate Med Ctr, Dept Pediat, Brooklyn, NY USA
基金
英国医学研究理事会;
关键词
continuous infection; Chlamydia pneumoniae; membrane protein; gene expression; real-time RT-PCR; persistence;
D O I
10.1016/S0882-4010(02)00187-0
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Chlamydia pneumoniae is associated with several chronic human diseases, including chronic obstructive pulmonary disease and atherosclerotic cardiovascular disease. During chronic disease, organisms are believed to exist in a persistent phase that is not well understood at the genetic level. Long-term in vitro continuous infections are spontaneously persistent and are less susceptible than in vitro acute infections to treatment with antibiotics, and are therefore particularly relevant as an in vitro model of in vivo chronic disease. Real-time reverse transcriptase-PCR (r-t RT-PCR) was used to quantitate transcript copy numbers of 13 genes in continuous and acute infections with C pneumoniae. The set of genes studied encodes proteins with known or predicted functions in the cell membrane, the inclusion membrane, cell division, metabolism, and immunopathology. Significant upregulation was seen for five genes (CPn0483, nlpD, ompA, pmp1 and porB) in continuous cultures. The genes omcB, pmp1, and porB, all of which encode membrane proteins, shared similar patterns of expression over both acute and continuous profiles. These results show that Chlamydia in the long-term continuous model of persistence have a unique transcription profile, adding to our knowledge of regulation of this important stage of chlamydial growth. Crown Copyright (C) 2003 Published by Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:11 / 16
页数:6
相关论文
共 37 条
[1]   Chlamydia pneumoniae infection in human monocytes [J].
Airenne, S ;
Surcel, HM ;
Alakärppä, H ;
Laitinen, K ;
Paavonen, J ;
Saikku, P ;
Laurila, A .
INFECTION AND IMMUNITY, 1999, 67 (03) :1445-1449
[2]   REACTIVATION OF PERSISTENT CHLAMYDIA-TRACHOMATIS INFECTION IN CELL-CULTURE [J].
BEATTY, WL ;
MORRISON, RP ;
BYRNE, GI .
INFECTION AND IMMUNITY, 1995, 63 (01) :199-205
[3]   MORPHOLOGIC AND ANTIGENIC CHARACTERIZATION OF INTERFERON GAMMA-MEDIATED PERSISTENT CHLAMYDIA-TRACHOMATIS INFECTION INVITRO [J].
BEATTY, WL ;
BYRNE, GI ;
MORRISON, RP .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (09) :3998-4002
[4]   CHLAMYDIA-TRACHOMATIS - ITS ROLE IN TUBAL INFERTILITY [J].
BRUNHAM, RC ;
MACLEAN, IW ;
BINNS, B ;
PEELING, RW .
JOURNAL OF INFECTIOUS DISEASES, 1985, 152 (06) :1275-1282
[5]   Chlamydia pneumoniae expresses genes required for DNA replication but not cytokinesis during persistent infection of HEp-2 cells [J].
Byrne, GI ;
Ouellette, SP ;
Wang, Z ;
Rao, JP ;
Lu, L ;
Beatty, WL ;
Hudson, AP .
INFECTION AND IMMUNITY, 2001, 69 (09) :5423-5429
[6]  
COLES AM, 1993, FEMS MICROBIOL LETT, V106, P193
[7]   Chronic infections and coronary heart disease: is there a link? [J].
Danesh, J ;
Collins, R ;
Peto, R .
LANCET, 1997, 350 (9075) :430-436
[8]   Persistence of Chlamydia trachomatis is induced by ciprofloxacin and ofloxacin in vitro [J].
Dreses-Werringloer, U ;
Padubrin, I ;
Jürgens-Saathoff, B ;
Hudson, AP ;
Zeidler, H ;
Köhler, L .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (12) :3288-3297
[9]  
Gérard HC, 1998, J RHEUMATOL, V25, P734
[10]   Chlamydia trachomatis genes whose products are related to energy metabolism are expressed differentially in active vs. persistent infection [J].
Gérard, HC ;
Freise, J ;
Wang, Z ;
Roberts, G ;
Rudy, D ;
Krauss-Patz, B ;
Köhler, L ;
Zeidler, H ;
Schumacher, HR ;
Whittum-Hudson, JA ;
Hudson, AP .
MICROBES AND INFECTION, 2002, 4 (01) :13-22